Fulcrum Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Fulcrum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fulcrum Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fulcrum Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $247k | 52k | 4.72 |
| 2024-09-30 | $128k | 36k | 3.58 |
| 2024-06-30 | $222k | 36k | 6.22 |
| 2024-03-31 | $151k | 16k | 9.50 |
| 2023-12-31 | $108k | 16k | 6.79 |
| 2023-09-30 | $71k | 16k | 4.47 |
| 2023-06-30 | $70k | 21k | 3.30 |
| 2023-03-31 | $104k | 37k | 2.85 |
| 2022-12-31 | $1.1M | 151k | 7.28 |
| 2022-03-31 | $596k | 25k | 23.65 |
| 2021-12-31 | $2.4M | 135k | 17.69 |
| 2021-09-30 | $1.3M | 44k | 28.22 |